We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.25 | 9.50 | 11.00 | 10.50 | 10.00 | 10.25 | 1,110,467 | 14:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.95 | 95.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/3/2018 09:04 | Tosh, Swimmer plot is here - slide no. 55. While you're at it, well worth spending 5 minutes really looking at figures on slide no. 56 too. hxxp://www.scancell. | bermudashorts | |
09/3/2018 08:47 | Timbo, I have just listened to last nights presentation and it sounded very positive, so lets hope that the muted " deal / s " come to fruition this year. The swimmer plot, also sounded very exciting, even though I obviously couldn't see it , I could visualise what it would look like. As people know, I'm not an RG fan ( too many false dawns ) so I am still somewhat wary of anything that comes out of his mouth, but all in all, I liked what I heard. Obviously, as has been said many times before, the term " cure " was clearly avoided and UNUSED by anyone, so our resident idiots claims that the company is using it, has been proven to be false, and again he has been proven to be a liar. What he said was, " that a cure was very hard to talk about, but that they are moving in the right direction " which is totally different to the cretins lies. Anyway, I'm looking forward to further updates as they become available and expect to see my shares steadily rise in value over the coming months, and a larger / quicker rise IF / WHEN the remaining question of further funding is dealt with ( hopefully, not via an additional raise ). Lets sit back and wait/ I'm more than comfortable with my holding. | tosh 123 | |
08/3/2018 23:25 | Timbo please post your comments tomorrow anyway - we can read them alongside Botski's. A pre comment from Botski,''Highlight is that we should be expecting some surprising left field announcements this year''. AND the recording is just posted now on LSE. Off to listen ! Thank you. | torquayfan | |
08/3/2018 23:03 | Did not know about presentation. It would be good to get latest news as I have a lot invested here and like to get good insight into science so I make good decisions. If you can summarise in an easy to understand way I would be grateful as I do find some of stuff complex. Thank you in advance for any informed comment rather than the usual rubbish some on here post | drdobson1 | |
08/3/2018 22:39 | It was RG who gave the presentation tonight and not CH as many were expecting. Apparently CH was busy with his move from Australia to the UK Botski made a sound recording of the presentation and as he was sitting in the front row, I will assume that the sound quality is going to be fairly reasonable. RG stayed for a good hour after the meeting, so there was time for a few questions. I will have a go at summarising those tomorrow, unless Botski beats me to it. | timbo003 | |
08/3/2018 19:24 | Bermuda shorties. Agree TOTALLY as the INAdequate one CLAIMS that EVERYTHING is DOWN to him. Let me inform you HIS LIES and CLAIMS are the ONLY thing down to him APART from his LOSS which goes DOWN as the shRe price GIES UP. The ASTUTE hAVe PROFITS that GO Up. | drdobson1 | |
08/3/2018 19:07 | boom - well initially at the 2013 ID Lindy described Moditope as cheap to produce. Whether the added cost of the adjuvant makes up for the dose reduction to micrograms I'm not sure but it should (if it were to be approved) be much more sustainable. | gooosed | |
08/3/2018 18:46 | Inan - I thought it might:) | bermudashorts | |
08/3/2018 18:44 | lozan switches to the privileged II you left wing nutter | inanaco | |
08/3/2018 18:42 | Boom ... the article backs me i am afraid as i suggested off label use as an adjuvant without a phase 3, but with a combi phase 3 approval | inanaco | |
08/3/2018 18:39 | Gooosed - yes it does. We tend to just focus on the US but when you look at the wider picture most healthcare systems in the World just can't afford to routinely use these treatments for all patients. In fact, I doubt whether the US can either. As these new immunotherapies are approved for more cancers and for use at earlier and earlier stages it surely will become unsustainable? Inan - have forgotten that debate. What was the outcome? | bermudashorts | |
08/3/2018 18:24 | *WE ALL* CAN see the trHYPERS trying to 'big themselves up' and STILL not able to {as opposed to WISER, more ASTUTE folks like Smiler... congrats by the way} Make / Take a PROFIT. Also *WE ALL* CAN see the tactic of 'Accusing others of THEIR CRIMES' posting style of LIES. Something that is being overlooked however, is = How long will it take , for those 'privalaged II's' who were GIVEN the chance by R G - whilst these 'crowing' - and ALL other shareholders were EXCLUDED - to 'clean-up' at 10p ... to begin to 'trouser' their PROFITS' ??? Those 'privalaged II's' have shareholders of their own to account to / face . What MIGHT the repercussions be if/when they REALISE their PROFITS ??? NO DOUBT = *WE ALL* will be misled by CLAIMS, that there is "NO RISK here" of those 'privalaged II's' REALISING their PROFITS. { Especially, IF they 'get wind' of a FUND raising in the offing} | the real lozan | |
08/3/2018 18:16 | You cannot help yourself your still trying to advise Tosh .. i retired 10 years ago ... LOL chill ... i don't need advice, if i had of listened to you, i would have sold at 10p and not come back for 2 years """"There appears to be a bit of consternation and surprise over on the other place, that the share price has dropped another 5% on the back of the interims... I'm really not sure why though, although no bad news was contained in the release, what it did do was to reinforce the fact that we can pretty much forget about this share for about 2 years, so, in the eyes of most investors, its better to put their money elsewhere, and take another look in about 18 months. The share price is stagnant, and will , I have no doubts, drop back into single figures, as foretold in numerous posts many months ago. The BOD are pretty much stuck at the moment unless a deal is done...unfortunately (tosh FCA Approved financial adviser 30th Jan. 2018) supported by Agent Cornflour and Lost the plot loz | inanaco | |
08/3/2018 18:13 | Tosh. Always appreciated your support when Nana attacked my military service and OF course we have a life outside of this board. Yes we should PITY him and his obsession with OTHER folk which is a clear sign of an INAdequte personality and needs to find fault in others to detract from HIS own failings. He pays lots of TAX well I bet he has TAKEN a lot more out of the system than PUT in unlike me and you. Have You met him OR do you make same assumptions as ME based on his rants. Off out to ENJOY the fruits of my Labour by taken the family to Nando’s tonight. Always good to appreciate good things in life | drdobson1 | |
08/3/2018 18:10 | Boomorbust ... we had a good debate on off label ref SCIB1 | inanaco | |
08/3/2018 18:03 | boom - that's the stat that caught my attention. Yes I agree & sympathise but it does underline the vast amount of headroom for improvements and the opportunities for potential treatments like Moditope and of course Immunobody. | gooosed | |
08/3/2018 17:54 | yep, somewhere between zip and zilch. Tosh can't even remember saying this just a few short weeks ago "The share price is stagnant, and will , I have no doubts, drop back into single figures, as foretold in numerous posts many months ago." And now claims to be 'ASStute' | fragma | |
08/3/2018 17:52 | Gooosed - thought provoking article, thanks for the link. Easy to be critical but if you're a doctor and the patient sitting in front of you has a terminal diagnosis and has failed all other treatments then your options are pretty limited. Can completely understand why they would want to prescribe something like a PD-1 off label. Not sure I believe their estimates that 50% to 75% of current oncology prescriptions are all off label. | bermudashorts | |
08/3/2018 17:51 | and i don't care tosh ... why should i ... ? how does it benefit me ? how many you have, I do know your investment in nipt at £5000 at 17p is sick and you did a buy in scancell at 26p ... your 6p shares are fake. if you had of asked agema he would have told you, Mr W never questions my holdings why, he knows i have lots. but we leave you posting like an idiot ... "its what you do" """"There appears to be a bit of consternation and surprise over on the other place, that the share price has dropped another 5% on the back of the interims... I'm really not sure why though, although no bad news was contained in the release, what it did do was to reinforce the fact that we can pretty much forget about this share for about 2 years, so, in the eyes of most investors, its better to put their money elsewhere, and take another look in about 18 months. The share price is stagnant, and will , I have no doubts, drop back into single figures, as foretold in numerous posts many months ago. The BOD are pretty much stuck at the moment unless a deal is done...unfortunately (tosh FCA Approved financial adviser 30th Jan. 2018) supported by Agent Cornflour and Lost the plot loz | inanaco | |
08/3/2018 17:37 | Tosh ... i have 500,000 ... from 8p upwards was in from the start, Agema and myself had a race to 300,000 under 12p trades poker face ... what i do is my business . but i pay tax and lots of it | inanaco | |
08/3/2018 17:32 | just bump this up a bit ....... """"There appears to be a bit of consternation and surprise over on the other place, that the share price has dropped another 5% on the back of the interims... I'm really not sure why though, although no bad news was contained in the release, what it did do was to reinforce the fact that we can pretty much forget about this share for about 2 years, so, in the eyes of most investors, its better to put their money elsewhere, and take another look in about 18 months. The share price is stagnant, and will , I have no doubts, drop back into single figures, as foretold in numerous posts many months ago. The BOD are pretty much stuck at the moment unless a deal is done...unfortunately (tosh FCA Approved financial adviser 30th Jan. 2018) supported by Agent Cornflour and Lost the plot loz | inanaco |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions